Clover Health
CLOV

Clover Health (CLOV) analyst forecast and price target

Analyst forecast

Hold

Consensus of 3 analyst ratings

Buy
1
Hold
2
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
UBSMaintainedNeutral$5.00 from $4.75Aug 6, 2026
Canaccord GenuityMaintainedBuy$5.50 from $4.20Jul 21, 2026
UBSMaintainedNeutral$4.75 from $2.75Jun 11, 2026
Canaccord GenuityMaintainedBuy$4.20 from $3.20Jun 4, 2026
Canaccord GenuityMaintainedBuy$3.20 from $3.70Mar 20, 2026
Leerink PartnersMaintainedMarket Perform$2.50 from $3.00Mar 5, 2026
Canaccord GenuityMaintainedBuy$3.70Jan 20, 2026
Canaccord GenuityMaintainedBuy$3.70 from $4.10Nov 6, 2025
Canaccord GenuityMaintainedBuy$4.10 from $4.50Aug 7, 2025
UBSMaintainedNeutral$3.00 from $4.50Aug 6, 2025
Canaccord GenuityMaintainedBuy$4.50 from $4.20Mar 3, 2025
Craig-HallumInitiated CoverageBuy$6.00Dec 17, 2024
UBSInitiated CoverageNeutral$4.00Oct 7, 2024
CitigroupMaintainedNeutral$1.50 from $1.00Aug 11, 2023
Canaccord GenuityMaintainedBuy$3.00 from $4.00Mar 6, 2023
Credit SuisseMaintainedUnderperform$1.25 from $2.50Mar 6, 2023

Frequently asked questions

  • Is CLOV a buy, sell, or hold?

    Analysts covering Clover Health currently average a Hold rating: 1 buy, 2 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on CLOV?

    On Aug 6, 2026, UBS maintained Clover Health at Neutral with a price target of $5.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.